Benchmark Reiterates Hold Rating on Neogenomics (NEO) on 2025 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq eyes lower open after midterms-fueled surge as chip, data center stocks fall
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Apple seeks to raise up to $7 billion in seven-tranche bond offering
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
| NEOGENOMICS (NASDAQ: NEO) | Delayed: 17.15 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.15 | 52 Week High | $9.54 | |||
| Open | $17.15 | 52 Week Low | $5.49 | |||
| Day High | $17.15 | P/E | 428.75 | |||
| Day Low | $17.15 | EPS | $0.04 | |||
| Volume | 13,653 | |||||
